Dual FLT3 inhibitors: Against the drug resistance of acute myeloid leukemia in recent decade

Ting Yuan(Goethe University Frankfurt), Jianyou Shi(University of Electronic Science and Technology of China), Wenjuan Dong(University of Electronic Science and Technology of China), Rongsheng Tong(University of Electronic Science and Technology of China), Lei Zhong(Shanghai Jiao Tong University), Jiying Yu(University of Electronic Science and Technology of China), Lan Bai(University of Electronic Science and Technology of China), Baowen Qi(Chengdu University), Zhongliang Jiang(North West Agriculture and Forestry University)
European Journal of Medicinal Chemistry
June 4, 2019
10.1016/j.ejmech.2019.06.002
Cited by 45

Related Papers

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.7k
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
|Cell|2010|1k
Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
|Signal Transduction and Targeted Therapy|2020|893
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
|Redox Biology|2018|753
The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism
|Cell|2012|662